{
    "clinical_study": {
        "@rank": "43641", 
        "brief_summary": {
            "textblock": "The purpose of this proposed Department of Defense study is to evaluate the effect of\n      Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood\n      pressure of type 2 diabetic patients receiving EECP therapy."
        }, 
        "brief_title": "Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "-Type 2 Diabetes Mellitus.", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age equal to or greater than 18.\n\n          2. Type 2 diabetes mellitus.\n\n          3. Enrollment in the Travis AFB, CA EECP Clinic.\n\n          4. Department of Defense Beneficiary.\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Department of Defense type 2 diabetic patients enrolled in the Travis AFB, CA EECP clinic."
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02040025", 
            "org_study_id": "FDG20140010H"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "hypertension", 
            "diabetes mellitus", 
            "hemoglobin A1C", 
            "peripheral vascular resistance", 
            "EECP", 
            "Blood pressure", 
            "angiogenesis", 
            "Coronary Artery Disease", 
            "Coronary Disease", 
            "Heart Diseases", 
            "Cardiovascular Diseases"
        ], 
        "lastchanged_date": "March 26, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Travis AFB", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94535"
                }, 
                "name": "David Grant USAF Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus", 
        "other_outcome": {
            "measure": "Change from baseline in mean resting peripheral blood pressure", 
            "safety_issue": "No", 
            "time_frame": "At baseline & post intervention, expected to be on average 10 minutes"
        }, 
        "overall_official": {
            "affiliation": "David Grant U.S. Air Force Medical Center", 
            "last_name": "Brad Williams, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in TCOM (Transcutaneous oximetry measurement) values", 
            "safety_issue": "No", 
            "time_frame": "At baseline & post intervention, expected to be on average 30 minutes"
        }, 
        "reference": [
            {
                "PMID": "22194326", 
                "citation": "Martin JS, Beck DT, Aranda JM Jr, Braith RW. Enhanced external counterpulsation improves peripheral artery function and glucose tolerance in subjects with abnormal glucose tolerance. J Appl Physiol (1985). 2012 Mar;112(5):868-76. doi: 10.1152/japplphysiol.01336.2011. Epub 2011 Dec 22."
            }, 
            {
                "PMID": "20921442", 
                "citation": "Braith RW, Conti CR, Nichols WW, Choi CY, Khuddus MA, Beck DT, Casey DP. Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation. 2010 Oct 19;122(16):1612-20. doi: 10.1161/CIRCULATIONAHA.109.923482. Epub 2010 Oct 4."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02040025"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Change from baseline in hemoglobin A1C laboratory values", 
            "safety_issue": "No", 
            "time_frame": "At baseline & post intervention, expected to be on average 30 minutes"
        }, 
        "source": "David Grant U.S. Air Force Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "David Grant U.S. Air Force Medical Center", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}